Cargando…

Lipid-Lowering Therapy after Acute Coronary Syndrome in Outpatient Practice—How to Achieve Goal

Background: Secondary prevention of cardiovascular disease involves the use of optimal pharmacological treatment and modification of risk factors through lifestyle changes. Recent evidence demonstrates that the major initiating event in atherogenesis is the storage of low-density lipoproteins. Objec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajtar-Salwa, Renata, Bobrowska, Beata, Batko, Jakub, Bartuś, Stanisław, Petkow-Dimitrow, Paweł, Krawczyk-Ożóg, Agata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607515/ https://www.ncbi.nlm.nih.gov/pubmed/37892717 http://dx.doi.org/10.3390/jcm12206579

Ejemplares similares

Anatomic Variations of Renal Arteries as an Important Factor in the Effectiveness of Renal Denervation in Resistant Hypertension
por: Kasprzycki, Karol, et al.
Publicado: (2023)

Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund
por: Bobrowska, Beata, et al.
Publicado: (2022)

Positron emission tomography for myocardial viability assessment before myocardial revascularization in a patient with extremely impaired left ventricular systolic function – advanced diagnosis and therapy in heart failure
por: Krawczyk-Ożóg, Agata, et al.
Publicado: (2017)

Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment
por: Dimitrow, Pawel Petkow, et al.
Publicado: (2016)

Redo of sympathetic renal denervation in a patient with resistant hypertension and anatomical variation of renal arteries
por: Kasprzycki, Karol, et al.
Publicado: (2023)

Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014
por: Rajtar-Salwa, Renata, et al.
Publicado: (2017)

Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014)
por: Hładij, Rafał, et al.
Publicado: (2017)

Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy
por: Rajtar-Salwa, Renata, et al.
Publicado: (2020)

Role of cardiac magnetic resonance in differentiating between acute coronary syndrome and apical hypertrophic cardiomyopathy
por: Rajtar-Salwa, Renata, et al.
Publicado: (2016)

Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy
por: Gębka, Adam, et al.
Publicado: (2018)

Anginal pain and elevated troponin level despite normal coronary angiography: hypertrophic cardiomyopathy with severe obstruction due to vasodilator/diuretic therapy for coincident arterial hypertension
por: Gębka, Adam, et al.
Publicado: (2018)

Hypertrophic Cardiomyopathy: The Time-Synchronized Relationship between Ischemia and Left Ventricular Dysfunction Assessed by Highly Sensitive Troponin I and NT-proBNP
por: Rajtar-Salwa, Renata, et al.
Publicado: (2019)

The diagnostic role of cardiac magnetic resonance used “first and last time in life” in a patient with a suspected dilated phase of hypertrophic cardiomyopathy
por: Hładij, Rafał, et al.
Publicado: (2017)

Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy
por: Gębka, Adam, et al.
Publicado: (2020)

The Impact of Age on the Physiological Assessment of Borderline Coronary Stenoses
por: Zasada, Wojciech, et al.
Publicado: (2023)

Computed tomography and transthoracic echocardiography for assessment of left ventricle geometry in patients with aortic valve stenosis
por: Krawczyk-Ożóg, Agata, et al.
Publicado: (2023)

Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension
por: Tokarek, Tomasz, et al.
Publicado: (2021)

Transthoracic Doppler echocardiography – noninvasive diagnostic window for coronary flow reserve assessment
por: Dimitrow, Paweł Petkow
Publicado: (2003)

Orthostatic stress echocardiography as a useful test to measure variability of transvalvular pressure gradients in aortic stenosis
por: Dimitrow, Pawel Petkow, et al.
Publicado: (2013)

Imaging of all three coronary arteries by transthoracic echocardiography. an illustrated guide
por: Krzanowski, Marek, et al.
Publicado: (2003)

Reduced coronary flow reserve in Anderson-Fabry disease measured by transthoracic Doppler echocardiography
por: Dimitrow, Paweł Petkow, et al.
Publicado: (2005)

The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography
por: Dimitrow, Pawel Petkow, et al.
Publicado: (2005)

Comparison of Fractional Flow Reserve with Resting Non-Hyperemic Indices in Patients with Coronary Artery Disease
por: Zdzierak, Barbara, et al.
Publicado: (2023)

Need for a standardized protocol for stress echocardiography in provoking subaortic and valvular gradient in various cardiac conditions
por: Petkow Dimitrow, Pawel, et al.
Publicado: (2014)

The thoracoacromial trunk: a detailed analysis
por: Bonczar, Michał, et al.
Publicado: (2022)

Predictors of Coronary and Carotid Atherosclerosis in Patients with Severe Degenerative Aortic Stenosis
por: Bobrowska, Beata, et al.
Publicado: (2013)

Assessment of mitral regurgitation and mitral complex geometry in patients after transcatheter aortic valve implantation
por: Sorysz, Danuta, et al.
Publicado: (2020)

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
por: Daida, Hiroyuki, et al.
Publicado: (2019)

Comparison of FFR, iFR, and QFR assessment in patients with severe aortic stenosis and coronary heart disease
por: Zasada, Wojciech, et al.
Publicado: (2022)

Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients
por: Karalis, Dean G., et al.
Publicado: (2012)

The Usefulness of [(18)F]F-Fluorodeoxyglucose and [(18)F]F-Sodium Fluoride Positron Emission Tomography Imaging in the Assessment of Early-Stage Aortic Valve Degeneration after Transcatheter Aortic Valve Implantation (TAVI)—Protocol Description and Preliminary Results
por: Sorysz, Danuta, et al.
Publicado: (2021)

Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus
por: García-Ulloa, Ana Cristina, et al.
Publicado: (2021)

Comparison of radiation dose exposure in patients undergoing percutaneous coronary intervention vs. peripheral intervention
por: Arif, Salech, et al.
Publicado: (2014)

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
por: Saito, Yasushi
Publicado: (2009)

A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients
por: Viola, Rebecca A, et al.
Publicado: (2002)

Achieve your goals
por: Smith, Andy
Publicado: (2006)

Cardiac hemangioma in the atrioventricular node localization
por: Batko, Jakub, et al.
Publicado: (2023)

Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved?: Results from the DA VINCI study
por: Siostrzonek, Peter, et al.
Publicado: (2021)

The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not At Goal study (SA-NAG)
por: Ramjeeth, Akash, et al.
Publicado: (2008)

Dissections after bioresorbable vascular scaffold implantation in the POLAR ACS Registry
por: Zasada, Wojciech, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_33usucbbl697gh4048peagsq19